CSC Global Financial Markets Acquires FIRSTCORP PTE. LTD in Singapore
CSC, a world leader in global business, legal, tax, and digital brand services, is pleased to announce that it has acquired FIRSTCORP PTE. LTD (FIRSTCORP) and its affiliates, a Singapore-based service provider of company secretary and administration services to corporations and alternative asset managers.
FIRSTCORP offers company formation, corporate secretarial, and domiciliation services. It specializes in the establishment and ongoing administration of Singapore companies as well as business entities in other key financial centers including Hong Kong, and other jurisdictions such as the British Virgin Islands, Cayman Islands, and Labuan. By managing the administrative and corporate secretarial compliance responsibilities of businesses operating in those jurisdictions—together with its strong network of partners—FIRSTCORP’s services enable its clients to navigate the increasingly complex international regulatory environment.
“We’re delighted to welcome FIRSTCORP to CSC, as the move strengthens our service offering in the Asia-Pacific market,” says CSC Executive Vice President John Hebert. “FIRSTCORP has an impressive track record and strong service-oriented culture similar to our own. Its jurisdictional expertise, bespoke solutions, and long-term approach to managing client relationships make it an excellent addition to our overall global offering.”
The acquisition of this Singapore-based business extends CSC’s capabilities for its Global Financial Markets (GFM) clients and boosts its physical presence in a leading Asia-Pacific (APAC) financial center. CSC already has an established team in Singapore, as well as additional APAC locations in Hong Kong, Shanghai, and Shenzhen. The acquisition follows several strategic hires and investments CSC has made in APAC in the last year, including scaling its fund administration offering and bolstering its international expansion businesses in the region. This has enabled CSC to provide administration services for corporations, family offices, and fund structures, such as Singapore variable capital companies (VCC), in addition to multiple structures related to venture capital, private equity, real estate, and trade finance and loan administration funds.
“Beyond extending our capabilities in APAC, this acquisition complements the market, regulatory, and jurisdictional expertise we provide to clients to help them achieve their business objectives,” says Agnes Chen, managing director of CSC’s APAC region. “Our ability to provide a wide range of support, from initial fund setup and onboarding to day-to-day administration of funds and investment structures and corporate services, is highly valued by clients and makes for a strong cultural fit between our respective organizations.”
FIRSTCORP was founded in 2003 and is centrally located in the heart of the Singapore business and financial district. All FIRSTCORP employees will join CSC as part of the acquisition.
“By joining forces with CSC, we’re reinforcing our local expertise with CSC’s global capabilities,” says FIRSTCORP Director Jenny Oh. “We share CSC’s vision of becoming the leading corporate service provider in our industry. And by joining together, we will be able to offer more services to our local clients, as well as expand our offerings to clients in North America, Europe, and the Asia Pacific Region.”
About CSC
CSC is a leading provider of specialized administration services to alternative asset managers across a range of fund strategies, capital markets participants in both public and private markets, and corporations requiring fiduciary and governance support. We are the unwavering partner for 90% of the Fortune 500®, nearly 10,000 law firms, and more than 3,000 financial institutions. CSC’s Global Financial Markets professionals are located in key financial centers across the U.S., Europe, and Asia-Pacific. We are a global company capable of conducting transactions wherever our clients are―and we accomplish that by deploying experts in every business we serve. For more information about CSC's services, visit cscgfm.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005079/en/
Contact information
Laura Crozier
Public Relations Manager
(302) 636 5401 x. 65526
CSC News Room
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
MarkLines Gen-AI Beta Version Released for Automotive Industry13.1.2026 02:00:00 EET | Press release
MarkLines Co., Ltd. (Headquarters: Minato-ku, Tokyo; President & CEO: Makoto Sakai; TYO:3901) announced its launch of the "MarkLines Gen-AI Beta Version," the new feature for B2B users in the automotive industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112383839/en/ "MarkLines Gen-AI Beta Version" can take questions in natural language and instantly give highly reliable, relevant data drawn from MarkLines’ extensive automotive database (Image: MarkLines Co., Ltd.) This AI-powered feature enables users to ask questions in natural language and instantly receive highly reliable, relevant data drawn from MarkLines’ extensive automotive database. Moreover, the system analyzes this information by leveraging the rich content across its platform and delivers clear, concise, text-based insights. By combining trusted data with advanced analytical capabilities through generative AI, this service represents a first-of-its-kind
Australian Defence Force Secures Satellite Communications on SES IS-2212.1.2026 23:30:00 EET | Press release
Satellite communications solutions provider SES will provide secure uninterrupted satellite communications to the Australian Defence Force (ADF) for a minimum of 16 years thanks to a new extended agreement. The service will be provided via the SES Intelsat 22 satellite and an ultra-high frequency (UHF) military communications payload. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112137182/en/ Assistant Secretary Space Systems Branch, Michael Hunt, formalizes contract negotiations for the through-life support of the IS-22 satellite with Rory Welch, senior vice-president of service delivery at SES Space and Defense. Photos: Corporal Annika Smit Under the renewed arrangement, SES will reposition the IS-22 satellite to a new orbital slot specified by the ADF, continuing a mission that has been the cornerstone of Australia’s secure military communications since IS-22’s launch in 2012. SES will build a dedicated ground segmen
NetApp Appoints Paul Fipps to the Board of Directors12.1.2026 23:05:00 EET | Press release
NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced that Paul Fipps, President of Global Customer Operations at ServiceNow, has joined its Board of Directors. The board now has ten directors, nine of whom are independent, and 50% of whom have been appointed within the last five years. Fipps brings more than 20 years of experience driving technology-enabled growth and customer transformation. At ServiceNow, he currently leads global sales, customer success, partner ecosystems, and field operations. He previously served as EVP of Worldwide Sales at ServiceNow and as President of Under Armour Connected Fitness and Chief Experience Officer at Under Armour, overseeing global direct-to-consumer, connected fitness, and digital experiences. He also previously served on the advisory board of Quantum Metric. Fipps holds a B.S. in Information Systems, an MBA from the University of Baltimore, and is a graduate of The Wharton School’s Advanced Management Program. “P
FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor12.1.2026 21:00:00 EET | Press release
Merck, a leading science and technology company, announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s new drug application (NDA) for pimicotinib as a systemic treatment for patients with tenosynovial giant cell tumor (TGCT). The application is based on the primary results and longer-term follow-up of the global Phase 3 MANEUVER study, which demonstrated deep and durable tumor responses and meaningful improvements in clinical outcomes with pimicotinib. “With pimicotinib, we have an opportunity to significantly advance care for people living with TGCT, a painful and debilitating disease that has few effective and well-tolerated treatment options beyond surgery,” said David Weinreich, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “Based on clinical trial results showing not only a reduction in tumor burden, but also the ability to help alleviate symptoms like pain and stiffness in the global Phase 3 MANEUVER study
Fabentech receives Marketing Authorization for Ricimed®, an antidote against ricin poisoning12.1.2026 20:32:00 EET | Press release
Fabentech, a French biopharmaceutical company specializing in medical countermeasures against biological threats, today announces that it has been granted Marketing Authorization for Ricimed®, a treatment for ricin poisoning. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112241557/en/ Ricimed - Fabentech Ricimed®, an antidote against one of the most toxic natural substances in the world In addition to supportive care, and in severe situations requiring immediate administration, Ricimed® represents a new therapeutic option for the management of acute ricin intoxication. Ricin, among the most dangerous naturally occurring substances, can cause death within hours or days regardless of the route of exposure, making it a major biological threat for many countries. Having demonstrated its ability to specifically target and neutralize ricin before irreversible damage occurs, Ricimed® is an antibody-based therapy relying on poly
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom